Language

News topic

Active ingredient DOCETAXEL

Current shortage notices for the active ingredient DOCETAXEL, structured by product, country and reporting period.

8 notices

← All shortages

What the DOCETAXEL notices indicate for the supply chain

The 8 consolidated notices from Czechia, Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Czechia

DOCETAXEL ACCORD 160MG/8ML INF CNC SOL 1X8ML

Active ingredient: DOCETAXEL

View notice details →
Czechia

DOCETAXEL ACCORD 20MG/1ML INF CNC SOL 1X1ML

Active ingredient: DOCETAXEL

View notice details →
Czechia

DOCETAXEL KABI 80MG/4ML INF CNC SOL 1X4ML

Active ingredient: DOCETAXEL

View notice details →
Belgium

Docetaxel Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 4 ml

Active ingredient: Docetaxel

View notice details →
Belgium

Docetaxel Accord 160 mg/8 ml inf. opl. (conc.) i.v. flac. 8 ml

Active ingredient: Docetaxel

View notice details →
Belgium

Docetaxel Accord 80 mg/4 ml inf. opl. (conc.) i.v. flac. 4 ml

Active ingredient: Docetaxel

View notice details →
Czechia

DOCETAXEL ACCORD 80MG/4ML INF CNC SOL 1X4ML

Active ingredient: DOCETAXEL

View notice details →
Czechia

DOCETAXEL KABI 20MG/1ML INF CNC SOL 1X1ML

Active ingredient: DOCETAXEL

View notice details →